AU6447690A - Method of administering soluble t4 for treatment of human immunodeficiency virus infection - Google Patents

Method of administering soluble t4 for treatment of human immunodeficiency virus infection

Info

Publication number
AU6447690A
AU6447690A AU64476/90A AU6447690A AU6447690A AU 6447690 A AU6447690 A AU 6447690A AU 64476/90 A AU64476/90 A AU 64476/90A AU 6447690 A AU6447690 A AU 6447690A AU 6447690 A AU6447690 A AU 6447690A
Authority
AU
Australia
Prior art keywords
treatment
immunodeficiency virus
virus infection
human immunodeficiency
administering soluble
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU64476/90A
Inventor
Randall T Curnow
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Corp
Original Assignee
SmithKline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Corp filed Critical SmithKline Beecham Corp
Publication of AU6447690A publication Critical patent/AU6447690A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
    • A61K38/1774—Immunoglobulin superfamily (e.g. CD2, CD4, CD8, ICAM molecules, B7 molecules, Fc-receptors, MHC-molecules)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU64476/90A 1989-09-18 1990-09-17 Method of administering soluble t4 for treatment of human immunodeficiency virus infection Abandoned AU6447690A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US40861789A 1989-09-18 1989-09-18
US408617 1989-09-18

Publications (1)

Publication Number Publication Date
AU6447690A true AU6447690A (en) 1991-04-18

Family

ID=23617014

Family Applications (1)

Application Number Title Priority Date Filing Date
AU64476/90A Abandoned AU6447690A (en) 1989-09-18 1990-09-17 Method of administering soluble t4 for treatment of human immunodeficiency virus infection

Country Status (4)

Country Link
AU (1) AU6447690A (en)
IE (1) IE903344A1 (en)
WO (1) WO1991004044A1 (en)
ZA (1) ZA907348B (en)

Also Published As

Publication number Publication date
IE903344A1 (en) 1991-04-10
ZA907348B (en) 1991-10-30
WO1991004044A1 (en) 1991-04-04

Similar Documents

Publication Publication Date Title
AU597635B2 (en) Treatment of diseases caused by retroviruses
HU9202616D0 (en) Method for preparing pharmaceutical preparatives serving for treatment of congestive heart diseases
AU6518890A (en) 6-amino-1,2-benzopyrones useful for treatment of viral diseases
AU4028895A (en) Vaccine and treatment method of Human Immunodeficiency Virus
AU6974687A (en) Treatment of immune diseases using diphenylhydantoin
AU4759390A (en) Method of medical treatment of alzheimer's disease
AU3413389A (en) Method of treating retrovirus infection
AU2807689A (en) Method for the treatment of body tissues and the administration of drugs thereto
AU5848794A (en) Multiple-gene mutants of human immunodeficiency virus (hiv) for vaccine use
AU5185790A (en) Treatment of tibial dyschondroplasia
AU5568290A (en) Method of suppressing hiv infection
AU1308188A (en) Methods of treating acquired immune deficiency syndrome (AIDS) caused by human immunodeficiency virus (HIV)
AU4602897A (en) Method for treatment of immunodeficiency virus infection
AU4328189A (en) Bile acids for treatment of viral infections
AU6877991A (en) A method of inactivating human immunodeficiency virus
AU591017B2 (en) Human monoclonal antibody and drug for prophylaxis and treatment of infectious diseases comprising same as effective ingredient
AU7481487A (en) Novel complexes, process for their preparation, and medicinal use of them
AU6447690A (en) Method of administering soluble t4 for treatment of human immunodeficiency virus infection
AU8185491A (en) Treatment of disease
IL102815A0 (en) Pharmaceutical compositions and method for the treatment of infection caused by the human immunodeficiency virus
AU1811388A (en) Method of treatment for retroviral infectious diseases
AU9495098A (en) Methods for use of interleukin 4 (il-4) to treat human immunodeficiency virus infection
AU3593095A (en) Method of treatment of human immunodeficiency virus (hiv) infection
AU6600190A (en) Therapeutic compositions; methods for treatment of hiv infections
AU4522089A (en) Medicament for treatment of pathological vascular permeability and plasma loss to tissue